Fennec Pharmaceuticals Inc (FRX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 7,262 | 25,377 | 9,735 | 6,515 | 3,325 |
| Cost of Goods | 608 | 550 | 685 | 331 | 148 |
| Gross Profit | 6,654 | 24,827 | 9,050 | 6,184 | 3,177 |
| Operating Expenses | 11,693 | 11,104 | 10,938 | 7,273 | 7,843 |
| Operating Income | -5,039 | 13,723 | -1,888 | -1,089 | -4,666 |
| Interest Expense | 1,044 | 1,034 | 915 | 856 | 825 |
| Other Income | 530 | 148 | 121 | 78 | 47 |
| Pre-tax Income | -5,553 | 12,837 | -2,682 | -1,867 | -5,444 |
| Net Income Continuous | -5,553 | 12,837 | -2,682 | -1,867 | -5,444 |
| Net Income | $-5,553 | $12,837 | $-2,682 | $-1,867 | $-5,444 |
| EPS Basic Total Ops | -0.20 | 0.47 | -0.10 | -0.07 | -0.21 |
| EPS Basic Continuous Ops | -0.20 | 0.47 | -0.10 | -0.07 | -0.21 |
| EPS Diluted Total Ops | -0.20 | 0.41 | -0.10 | -0.07 | -0.21 |
| EPS Diluted Continuous Ops | -0.20 | 0.41 | -0.10 | -0.07 | -0.21 |
| EBITDA(a) | $-4,483 | $14,594 | $-1,697 | $-939 | $-4,619 |